Patents by Inventor Nacima Demil

Nacima Demil has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10434147
    Abstract: A pharmaceutical combination for use in glycemic control in a type 2 diabetes mellitus patient, said combination comprising (i) lixisenatide or/and a pharmaceutically acceptable salt thereof, (ii) insulin glargine or/and a pharmaceutically acceptable salt thereof, and (iii) optionally metformin or/and a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: July 11, 2017
    Date of Patent: October 8, 2019
    Assignee: SANOFI-AVENTIS DEUTSCHLAND GMBH
    Inventors: Christine Roy, Elisabeth Souhami, Nacima Demil, Jenny Ye
  • Publication number: 20180092965
    Abstract: A pharmaceutical combination for use in glycemic control in a type 2 diabetes mellitus patient, said combination comprising (i) lixisenatide or/and a pharmaceutically acceptable salt thereof, (ii) insulin glargine or/and a pharmaceutically acceptable salt thereof, and (iii) optionally metformin or/and a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: July 11, 2017
    Publication date: April 5, 2018
    Inventors: Christine Roy, Elisabeth Souhami, Nacima Demil, Jenny Ye
  • Publication number: 20160287674
    Abstract: A pharmaceutical combination for use in glycemic control in a type 2 diabetes mellitus patient, said combination comprising (i) lixisenatide or/and a pharmaceutically acceptable salt thereof, (ii) insulin glargine or/and a pharmaceutically acceptable salt thereof, and (iii) optionally metformin or/and a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: March 11, 2016
    Publication date: October 6, 2016
    Inventors: Christine Roy, Elisabeth Souhami, Nacima Demil, Jenny Ye